Trials / Recruiting
RecruitingNCT07004192
The Role of hCG in Thawed Embryo Transfer
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Fertility Center of Las Vegas · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.
Detailed description
The current study is designed to carefully isolate the effect of a corpus luteum by ensuring that the presence or absence of a corpus luteum is the only difference between two study arms. This should be reliably achieved by administering an injection of hCG in one study arm, while the other study arm has identical treatment except for omitting the hCG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HCG injection | 5000 IU hCG injection |
| OTHER | No intervention | No hCG administered in this group. |
Timeline
- Start date
- 2025-06-02
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2025-06-04
- Last updated
- 2025-07-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07004192. Inclusion in this directory is not an endorsement.